Does Acalabrutinib Fit Into Frontline MCL Therapy?

Results of ECOG-ACRIN EA4181 support moving away from high-dose cytotoxic therapy and toward targeted therapy in frontline management of mantle cell lymphoma.
Medscape Medical News

source https://www.medscape.com/viewarticle/does-acalabrutinib-fit-frontline-mcl-therapy-2024a1000mpa?src=rss